Reduced fluid intake due to nausea, combined with fluid losses from vomiting or diarrhea, can lead to volume depletion
If you are ready to stop the cycle of frustration and start a program built on science and support, the next step is simple
The compound emerged from Eli Lillys discovery program seeking to combine the complementary metabolic signaling of GLP-1, GIP, and glucagon receptor activation into a single chemical entity (Coskun et al., 2022)
It is often part of a broader protocol that may include other peptides, supplements, or lifestyle interventions
Retatrutide: Designed to Last One of the newest GLP-1 medications in development is retatrutide , a triple agonist (GLP-1, GIP, and glucagon receptors) designed with an approximate 6-day half-life , thanks to advanced pharmaceutical engineering
The four-week intervals at each dose level allow GI adaptation